| Date Checked | 2025-12-21 23:36:14 |
|---|---|
| Graham Number | (PB)74.48 vs (PE)127.06 |
| Over / Under Value Percentage | 799.22% vs 728.62% |
| Dividend Yield | 0.00% |
| Dividend Date | None |
| Symbol | IDXX |
| AssetType | Common Stock |
| Name | IDEXX Laboratories Inc |
| Description | IDEXX Laboratories, Inc. is a leading American multinational firm specializing in advanced diagnostics and software solutions for the veterinary, livestock, and water testing industries. Recognized for its innovative technologies, IDEXX enhances the quality of veterinary care and delivers reliable testing solutions to agriculture sectors, thus addressing critical demands in food safety and animal health. With a robust commitment to research and development, the company is well-positioned for continued growth, capitalizing on the increasing global focus on companion animal health and overall food safety. IDEXX's strategic leadership in these areas solidifies its stance as a key player in improving health outcomes across various animal populations. |
| CIK | 874716 |
| Exchange | NASDAQ |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DIAGNOSTICS & RESEARCH |
| Address | ONE IDEXX DRIVE, WESTBROOK, ME, UNITED STATES, 04092 |
| OfficialSite | https://www.idexx.com |
| FiscalYearEnd | December |
| LatestQuarter | 2025-09-30 |
| MarketCapitalization | 57400967000 |
| EBITDA | 1437280000 |
| PERatio | 56.81 |
| PEGRatio | 4.287 |
| BookValue | 19.52 |
| DividendPerShare | None |
| EPS | 12.63 |
| RevenuePerShareTTM | 51.5 |
| ProfitMargin | 0.246 |
| OperatingMarginTTM | 0.321 |
| ReturnOnAssetsTTM | 0.241 |
| ReturnOnEquityTTM | 0.646 |
| RevenueTTM | 4167411000 |
| GrossProfitTTM | 2572125000 |
| DilutedEPSTTM | 12.63 |
| QuarterlyEarningsGrowthYOY | 0.214 |
| QuarterlyRevenueGrowthYOY | 0.133 |
| AnalystTargetPrice | 759 |
| AnalystRatingStrongBuy | 3 |
| AnalystRatingBuy | 5 |
| AnalystRatingHold | 5 |
| AnalystRatingSell | 1 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 56.81 |
| ForwardPE | 50.76 |
| PriceToSalesRatioTTM | 13.77 |
| PriceToBookRatio | 37.13 |
| EVToRevenue | 14.13 |
| EVToEBITDA | 40.58 |
| Beta | 1.687 |
| 52WeekHigh | 769.98 |
| 52WeekLow | 356.14 |
| 50DayMovingAverage | 669.73 |
| 200DayMovingAverage | 556.73 |
| SharesOutstanding | 79851000 |
| SharesFloat | 78982000 |
| PercentInsiders | 0.684 |
| PercentInstitutions | 95.369 |
| ExDividendDate | None |
| dateChecked | 2025-12-21 23:36:14 |
| fresh | 1 |